Published in Blood Weekly, September 18th, 2003
"Delayed hematopoietic recovery is the main factor precluding a wider use of cord blood (CB) transplants," scientists in Italy explained.
F. Frassoni and colleagues at San Martino Hospital in Genova "hypothesized that this delayed engraftment might not be related to an insufficient number of stem cells in the graft, but to an intrinsic difficulty of these cells to undergo differentiation."
"To test our hypothesis, two groups of children were compared; 12 received a CB transplant and 12 an adult...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.